Lumbard & Kellner, LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 299 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.

Quarter-by-quarter ownership
Lumbard & Kellner, LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q4 2022$1,961,606
+19.2%
125,744
-0.9%
0.96%
+13.3%
Q3 2022$1,646,000
-9.6%
126,946
-2.0%
0.85%
-8.7%
Q2 2022$1,820,000
-4.1%
129,597
-2.2%
0.93%
+25.4%
Q1 2022$1,898,000
-0.9%
132,5160.0%0.74%
+2.6%
Q4 2021$1,916,000
-14.4%
132,516
-3.1%
0.72%
-17.8%
Q3 2021$2,239,000
-3.4%
136,693
-0.8%
0.88%
-2.1%
Q2 2021$2,318,000
+2.4%
137,749
+1.6%
0.90%
+12.7%
Q1 2021$2,264,000
-5.8%
135,550
-0.6%
0.80%
-15.9%
Q4 2020$2,404,000
+13.7%
136,378
-0.8%
0.95%
-9.3%
Q3 2020$2,115,000
-4.0%
137,430
+11.9%
1.04%
-17.5%
Q2 2020$2,202,000
+13.0%
122,785
-4.4%
1.27%
-3.1%
Q1 2020$1,949,000
-25.9%
128,421
-3.7%
1.31%
-3.9%
Q4 2019$2,632,000
+14.4%
133,402
-0.3%
1.36%
+7.9%
Q3 2019$2,301,000
-2.8%
133,8040.0%1.26%
-0.9%
Q2 2019$2,368,000
-13.2%
133,804
-0.1%
1.27%
-16.2%
Q1 2019$2,729,000133,9801.52%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2021
NameSharesValueWeighting ↓
Glenview Capital Management 16,104,222$294,063,0004.98%
GMT CAPITAL CORP 2,468,695$45,078,0003.31%
MANAGED ASSET PORTFOLIOS, LLC 1,065,756$19,461,0003.13%
Blackcrane Capital, LLC 14,571$1,723,0002.72%
BFAM Partners (Cayman) Ltd 328,690$6,002,0002.36%
Paulson & Co. 4,727,415$86,323,0001.98%
Mondrian Investment Partners LTD 3,510,404$59,677,0001.28%
Lumbard & Kellner, LLC 135,550$2,264,0000.80%
DAVIDSON INVESTMENT ADVISORS 500,203$9,134,0000.78%
TFG Asset Management GP Ltd 589,390$10,762,0000.77%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders